Pre-hospital management of pain associated with an acute sickle cell crisis
Journal of Paramedic Practice · 2017-07-02 · Other / unclear
Abstract
Sickle Cell Disease and its acute manifestation as a sickle cell crisis has a severely deleterious effect on predicted mortality and quality of life of its sufferers. Serious sequelae can occur, resulting in severe neurological and cardiovascular impairment. In the majority of cases these patients will present to pre-hospital clinicians with acute intractable pain unmanaged by the patient's own analgesia. Unfortunately, some evidence reports that pain is commonly under-treated with assumptions made about drug-seeking behaviour. The evidence presented in this paper will indicate that Entonox should no longer be routinely used for the management of sickle cell pain. Instead, emphasis should turn to the use of potent intravenous opiates (where intravenous access can be reliably and aseptically gained). The use of diamorphine and ketamine for extreme pain should be investigated by pre-hospital services, as should the use of non-steroidal anti-inflammatory drugs.
Abstract © the authors or publisher, via OpenAlex. Reuse and removal
Tags
Anaesthetics · Analgesics · Intravenous access · Ketamine · Nitrous oxide · NSAIDs · Quality of life & function
Related articles
- Evidence-Based Guidelines for Prehospital Pain Management: Recommendations. (Prehosp Emerg Care, 2023)
- Pain management of adults in the prehospital setting: a scoping review. (BMC Emerg Med, 2026)
- [Guideline 'Pain management for trauma patients in the chain of emergency care']. (Ned Tijdschr Geneeskd, 2011)
- Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting. (Prehosp Emerg Care, 2020)
- Variability of Prehospital Pain Management Protocols: A Review of Prehospital Care Protocols in the United States. (Open Access Emerg Med, 2024)
- Application of analgesics in emergency services in Germany: a survey of the medical directors. (BMC Emerg Med, 2023)